Prevention of Group B Streptococcus early-onset disease: a toolkit by the California Perinatal Quality Care Collaborative

J Perinatol. 2010 Feb;30(2):77-87. doi: 10.1038/jp.2009.95. Epub 2009 Aug 6.

Abstract

The California Perinatal Quality Care Collaborative (CPQCC) was organized in 1996 in an effort to improve perinatal outcomes in California. CPQCC has a robust infrastructure of quality improvement resources and expertise and uses a database of demographic and outcome data from neonatal intensive care units in California. In 2004, CPQCC developed a toolkit to provide an evidence-based framework and supporting documents for hospitals to use in systematically addressing persistent early-onset disease (EOD) because of Group B Streptococcus (GBS) in their centers. The CPQCC toolkit was based on the 2002 Centers for Disease Control guideline, 'Prevention of Perinatal Group B Streptococcal Disease.' This article presents an updated version of the CPQCC toolkit reflecting several population studies published since the 2002 guideline. Current epidemiological trends in incidence of EOD with GBS, changes in antibiotic sensitivity and the potential value of newer strategies are discussed.

Publication types

  • Practice Guideline

MeSH terms

  • Algorithms
  • Antibiotic Prophylaxis*
  • California / epidemiology
  • Carrier State / diagnosis
  • Carrier State / prevention & control
  • Carrier State / transmission
  • Drug Resistance, Multiple, Bacterial
  • Female
  • Fetal Membranes, Premature Rupture / microbiology
  • Humans
  • Incidence
  • Infant, Newborn
  • Infectious Disease Transmission, Vertical / prevention & control*
  • Mass Screening
  • Pregnancy
  • Pregnancy Complications, Infectious / diagnosis
  • Pregnancy Complications, Infectious / epidemiology
  • Pregnancy Complications, Infectious / prevention & control
  • Prenatal Diagnosis
  • Streptococcal Infections / epidemiology
  • Streptococcal Infections / prevention & control*
  • Streptococcal Infections / transmission*
  • Streptococcus agalactiae* / drug effects